CLINICAL_TRIALS
trial_result
· 2016-04-27
Clinical Trial Update: Bioequivalence Study Coadministered to Healthy Subjects in the Fasted State [Phase 1]
Summary
A Phase 1 bioequivalence study in healthy fasting subjects involving a diabetes drug candidate has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED | Results posted: 2016-04-27